Successfully Completed Seed Funding Round
- Makoto Yamamoto
- Jan 31, 2024
- 1 min read
2024年1月31日
We have successfully closed our seed funding round to accelerate the development of our nucleic acid therapeutics and synthesis technologies.
Read more
top of page
Search
bottom of page
Comments